Genaco Biomedical Products, Inc.

2707 Artie Street Building 100, Suite 20
Huntsville, AL 35805
http://www.genaco.com
10 Employees

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $602K
First Award Date 02/01/99
Most Recent Award Date 09/26/06

Key Personnel

Last Name Name Awards Contact
Han Dr. Jian Han 5 Message
Lu Chiung-Mei Lu 2

7 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/26/06 - 08/31/07

DESCRIPTION (provided by applicant): The aim of this SBIR application is to develop a bead based array system for the specific detection and classification of microRNAs. The discovery of miRNAs representing a paradigm shift that suggested the existence of many unknown cellular function and regulation mechanisms. Already, miRNAs have been found i...

Phase 1 SBIR

Agency: Army
Topic: A05-166
Budget: 12/01/05 - 05/31/06

Polymerase Chain Reaction (PCR) is a well-established molecular diagnostic method. The use of PCR for molecular differential diagnosis, however, requires multiplex capability (i.e. the ability to amplify multiple pathogen targets in a single reaction). Genaco has developed a proprietary technology, Target enriched multiplex PCR (Tem-PCR), that a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-05-06
Budget: 06/01/05 - 11/30/05

DESCRIPTION (provided by applicant): The aim of this SBIR application is to develop a bead-based array system for the specific detection and classification of microRNAs (miRNAs). The discovery of miRNAs represents a paradigm shift that suggests the existence of many unknown cellular function and regulation mechanisms. Already, miRNAs have been ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/04 - 04/30/05

HPV infection could cause cervical cancer. World wide, cervical cancer is the second most common cancer among women. In the US, it is responsible for approximately 13,000 new cases and 4,500 daths each year. While a Pap test can recognize the possibility of cervical cancer, a more direct HPV (Human Papillomavirus) molecular test would be welcome...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/15/03 - 05/31/04

DESCRIPTION (provided by applicant): Recurrent chromosome translocations in leukemias are useful cytogenetic markers for monitoring diagnosis, prognosis and treatment. Traditional cytogenetic study cannot recognize all the gene rearrangements at the molecular level. Also, it is a time consuming and labor intensive procedure. We have developed a ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/99 - 01/31/00

Acute Lymphoblastic Leukemia (ALL) is the most common malignancy of childhood. Recurrent chromosome translocations in childhood leukemia are useful cytogenetic markers for diagnosis, prognosis and treatment monitoring. For example, the presence of certain specific translocations, including t(1 ;19), t(9...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/99 - 07/31/99

Gene dosage abnormalities may occur at gene level (such as a thalassemias), subchromosome level (such as contiguous gene syndromes), or chromosome level (aneuploidy). The objective of this project is to develop molecular diagnostic kits for thedetection of common aneuploidies and contiguous gene syndromes. A methodology has been developed by Gen...